{{Rsnum
|rsid=4453795
|Gene=FGF12
|Chromosome=3
|position=192376186
|Orientation=plus
|GMAF=0.455
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=FGF12
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 36.3 | 50.4 | 13.3
| HCB | 35.8 | 46.7 | 17.5
| JPT | 34.5 | 47.8 | 17.7
| YRI | 10.4 | 42.4 | 47.2
| ASW | 10.5 | 40.4 | 49.1
| CHB | 35.8 | 46.7 | 17.5
| CHD | 38.0 | 44.4 | 17.6
| GIH | 23.8 | 40.6 | 35.6
| LWK | 33.0 | 40.4 | 26.6
| MEX | 41.4 | 43.1 | 15.5
| MKK | 12.2 | 50.6 | 37.2
| TSI | 33.3 | 50.0 | 16.7
| HapMapRevision=28
}}
{{PMID Auto GWAS
|PMID=19043545
|Trait=Serum metabolites
|Title=Genetics Meets Metabolomics: A Genome-Wide Association Study of Metabolite Profiles in Human Serum
|RiskAllele=
|Pval=4E-7
|OR=NR
|ORtxt=NR
|OA=1
}}

{{PharmGKB
|RSID=rs4453795
|Name_s=
|Gene_s=FGF12
|Feature=
|Evidence=PubMed ID:19043545; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genetics Meets Metabolomics: A Genome-Wide Association Study of Metabolite Profiles in Human Serum. (Initial Sample Size: 284 males; Replication Sample Size: NR); (Region: 3q28; Reported Gene(s): FGF12; Risk Allele: rs4453795-?); (p-value= 0.0000004).This variant is associated with Serum metabolites.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740305
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs4453795
|overall_frequency_n=48
|overall_frequency_d=106
|overall_frequency=0.45283
|n_genomes=28
|n_genomes_annotated=0
|n_haplomes=40
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}